Evidence map›Paper›PMID 35960905›Full record

ReviewJCO global oncology2022

Access to Radiation Therapy: From Local to Global and Equality to Equity.

Sarbani Ghosh Laskar, Shwetabh Sinha, Rahul Krishnatry, Cai Grau, Minesh Mehta, Jai Prakash Agarwal

Abstract readReview
In one paragraph

Review in JCO global oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Improving Access to Radiotherapy in Gauteng: A Framework for Equitable Cancer Care.International journal of environmental research and public health · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Access to brachytherapy treatment for cervical cancer management in Africa.Clinical and translational radiation oncology · 2025
    Review
  18. Article
  19. Article
  20. ASPRONET: A facilitated online education project for radiation therapists in the Asia-Pacific region.Technical innovations & patient support in radiation oncology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sarbani Ghosh LaskarDepartment of Radiation Oncology, Homi Bhabha National Institute, Tata Memorial Centre, Mumbai, India.ORCID 0000-0003-0744-4838
Shwetabh SinhaDepartment of Radiation Oncology, Homi Bhabha National Institute, Tata Memorial Centre, Mumbai, India.ORCID 0000-0003-3369-3870
Rahul KrishnatryDepartment of Radiation Oncology, Homi Bhabha National Institute, Tata Memorial Centre, Mumbai, India.ORCID 0000-0003-4511-7782
Cai GrauDepartment of Radiation Oncology and Danish Center for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark.ORCID 0000-0003-3548-3527
Minesh MehtaDepartment of Radiation Oncology, Miami Cancer Institute, Miami, FL.ORCID 0000-0002-4812-5713
Jai Prakash AgarwalDepartment of Radiation Oncology, Homi Bhabha National Institute, Tata Memorial Centre, Mumbai, India.ORCID 0000-0003-0430-8558

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The discipline of radiation oncology is the most resource-intensive component of comprehensive cancer care because of significant initial investments required for machines, the requirement of dedicated construction, a multifaceted workforce, and recurring maintenance costs. This review focuses on the challenges associated with accessible and affordable radiation therapy (RT) across the globe and the possible solutions to improve the current scenario. Most common cancers globally, including breast, prostate, head and neck, and cervical cancers, have a RT utilization rate of > 50%. The estimated annual incidence of cancer is 19,292,789 for 2020, with > 70% occurring in low-income countries and low-middle-income countries. There are approximately 14,000 teletherapy machines globally. However, the distribution of these machines is distinctly nonuniform, with low-income countries and low-middle-income countries having access to < 10% of the global teletherapy machines. The Directory of Radiotherapy Centres enlists 3,318 brachytherapy facilities. Most countries with a high incidence of cervical cancer have a deficit in brachytherapy facilities, although formal estimates for the same are not available. The deficit in simulators, radiation oncologists, and medical physicists is even more challenging to quantify; however, the inequitable distribution is indisputable. Measures to ensure equitable access to RT include identifying problems specific to region/country, adopting indigenous technology, encouraging public-private partnership, relaxing custom duties on RT equipment, global/cross-country collaboration, and quality human resources training. Innovative research focusing on the most prevalent cancers aiming to make RT utilization more cost-effective while maintaining efficacy will further bridge the gap.

Indexed as

BrachytherapyNeoplasmsRadiation OncologyComprehensive Health CareHumansMaleWorkforce

Identifiers

PMID35960905
PMCPMC9470145

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.